ALLISON MCCLANAHAN: Open Payments
NPI 1649726670 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,952 in 89 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,179 · 2025 $1,952
Food & beverage: $1,819Education: $133
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $424 |
| AstraZeneca Pharmaceuticals LP | 13 | $307 |
| Amgen Inc. | 11 | $257 |
| GlaxoSmithKline, LLC. | 13 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $214 |
| CSL Behring | 8 | $188 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| GENZYME CORPORATION | 3 | $61 |
| Cycle Pharmaceuticals Inc | 2 | $49 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
Products named: DUPIXENT, TEZSPIRE, CUVITRU, AIRSUPRA, TRELEGY ELLIPTA, Andembry, NUCALA, FASENRA.
Industry payments across KY — which companies pay providers there.
